Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations

Roberts, H. J., Ji, S., Picca, A., Sanson, M., Garcia, M., Snuderl, M., … Koschmann, C. (2023, December 1). Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations. Acta Neuropathologica. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s00401-023-02640-7